IN2014MN02080A - - Google Patents
Info
- Publication number
- IN2014MN02080A IN2014MN02080A IN2080MUN2014A IN2014MN02080A IN 2014MN02080 A IN2014MN02080 A IN 2014MN02080A IN 2080MUN2014 A IN2080MUN2014 A IN 2080MUN2014A IN 2014MN02080 A IN2014MN02080 A IN 2014MN02080A
- Authority
- IN
- India
- Prior art keywords
- ala
- amino acids
- following amino
- shaped
- following
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
?What are proposed are: synthetic peptides having a non narcotic type of analgesic effect of general formula 1 [SEQ ID NO:1] where: H is hydrogen XDL is an omission of an amino acid or is L Tyr XDL1 is one of the following amino acids: L Leu L Ala or D Ala XDL2 is one of the following amino acids: L His D His L Ala or D Ala XDL3 is one of the following amino acids: L Gln L Ala or D Ala; R2 is ??? or NH2 and also retro inversion peptides of formula (I) having a reverse sequence of amino acids with L shaped amino acids being substituted by D shaped amino acids and D shaped amino acids being substituted by L shaped amino acids of general formula 2 [SEQ ID NO:2] where: H is hydrogen XDL4 is one of the following amino acids: D GIn D Ala or L Ala XDL5 is one of the following amino acids: D His L His D Ala or L Ala XDL6 is one of the following amino acids: D Leu D Ala or L Ala XDL7 is an omission of an amino acid or is D Tyr R2 is ??? or NH2.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012110908/10A RU2508295C2 (en) | 2012-03-22 | 2012-03-22 | Synthetic peptides with non-narcotic type of analgetic action |
| PCT/RU2012/001036 WO2013141750A1 (en) | 2012-03-22 | 2012-12-07 | Synthetic peptides wtih a non-narcotic type of analgesic effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02080A true IN2014MN02080A (en) | 2015-08-21 |
Family
ID=49223070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2080MUN2014 IN2014MN02080A (en) | 2012-03-22 | 2012-12-07 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9260482B2 (en) |
| EP (1) | EP2848629B1 (en) |
| JP (1) | JP6118392B2 (en) |
| CA (1) | CA2867994C (en) |
| ES (1) | ES2651265T3 (en) |
| IN (1) | IN2014MN02080A (en) |
| RU (1) | RU2508295C2 (en) |
| WO (1) | WO2013141750A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2678571C1 (en) * | 2013-12-19 | 2019-01-30 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain |
| DE102016125645A1 (en) | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomeric peptides for the treatment of chronic and neuropathic pain |
| RU2651491C1 (en) | 2017-04-07 | 2018-04-19 | Общество с ограниченной ответственностью "Биофармокс" | Specific peptide clathrin inhibitors |
| US20210228677A1 (en) * | 2020-01-28 | 2021-07-29 | Pharmbiotech OY | Pharmaceutical composition and a method for its manufacture |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229658B (en) | 1989-04-21 | 1991-09-06 | Eniricerche Spa | BACK-REVERSE THYOPENTINE ANALOGUES WITH ONE OR MORE LINKS, THE METHOD FOR THEIR SYNTHESIS AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. |
| US5175146A (en) * | 1989-12-05 | 1992-12-29 | Vical, Inc. | Synthetic calcitonin peptides |
-
2012
- 2012-03-22 RU RU2012110908/10A patent/RU2508295C2/en active IP Right Revival
- 2012-12-07 EP EP12871733.7A patent/EP2848629B1/en active Active
- 2012-12-07 CA CA2867994A patent/CA2867994C/en active Active
- 2012-12-07 ES ES12871733.7T patent/ES2651265T3/en active Active
- 2012-12-07 JP JP2015501616A patent/JP6118392B2/en active Active
- 2012-12-07 IN IN2080MUN2014 patent/IN2014MN02080A/en unknown
- 2012-12-07 WO PCT/RU2012/001036 patent/WO2013141750A1/en active Application Filing
- 2012-12-07 US US14/386,675 patent/US9260482B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6118392B2 (en) | 2017-04-19 |
| CA2867994C (en) | 2017-05-16 |
| RU2012110908A (en) | 2013-09-27 |
| JP2015512385A (en) | 2015-04-27 |
| EP2848629A4 (en) | 2016-03-02 |
| US20150073123A1 (en) | 2015-03-12 |
| CA2867994A1 (en) | 2013-09-26 |
| EP2848629B1 (en) | 2017-09-06 |
| ES2651265T3 (en) | 2018-01-25 |
| RU2508295C2 (en) | 2014-02-27 |
| US9260482B2 (en) | 2016-02-16 |
| WO2013141750A1 (en) | 2013-09-26 |
| EP2848629A1 (en) | 2015-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ628446A (en) | Fibronectin based scaffold domain proteins that bind to myostatin | |
| CO6241137A2 (en) | CXCR4 CYCLE PEPTIDE ANTAGONISTS | |
| NZ603016A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
| IN2014CN04498A (en) | ||
| NZ604412A (en) | Vaccine and methods to reduce campylobacter infection | |
| NZ602845A (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| WO2015065867A3 (en) | Peripheral kappa opioid receptor agonists for preventing, inhibiting or treating nausea and vomiting | |
| IN2014MN02080A (en) | ||
| NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
| EA201390820A1 (en) | Fusion protein against cancer | |
| EA033437B1 (en) | Fc GAMMA RECEPTOR IIB AND USE THEREOF FOR TREATING OR PREVENTING INFLAMMATORY AND/OR AUTOIMMUNE DISEASES | |
| NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
| GB2517354A (en) | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy | |
| NZ756128A (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
| SG195302A1 (en) | Shk-based pharmaceutical compositions and methods of manufacturing and using the same | |
| BR112012017093A2 (en) | organic compounds for the regulation of vector ion channels | |
| MX2015002279A (en) | Synthetic pntx(19) peptide, pharmaceutical compositions and use. | |
| RU2013119051A (en) | TETRAPEPTIDE AND MEANS WITH CEREBROPROTECTIVE AND ANTIAMNESTIC ACTIVITY | |
| WO2012120315A3 (en) | Mutant proteins and methods for producing them | |
| NZ621552A (en) | Pest-controlling agents isolated from spider venom and uses thereof | |
| EA201592019A1 (en) | LYOPHYLIZATE CONTAINING A CYCLIC PEPTIDE OF THE FORMULA X-GQRETPEGAEAKPWY-X | |
| WO2018031730A3 (en) | Peptide inhibitors of phosphoglycerate mutase and methods of use | |
| NZ706202A (en) | Peptide antagonists of the vasopressin-2 receptor | |
| GB2517871A (en) | Alternaria peptides | |
| DK201370709A (en) | Protein for use as a medicament |